COVID‑19 Alert: Stay home if you feel unwell. If you have a fever, cough and difficulty breathing, seek medical attention. Follow the directions of your local health authority. Source WHO

We have a lockdown, "Working from HOME" Please reach out for any queries at: help@alliedmarketresearch.com & Int'l : +1-503-894-6022, (UK) : +44-845-528-1300

Europe In Vitro Fertilization Market Expected to Reach $4,447 Million, by 2022


quote The presence of regulatory and reimbursement policies such as three-parent IVF treatments and HFEA guidelines contribute to high market growth. quote

Pallavi Jaiswal
Analyst at Allied Market Research.

Get 20% Free Customization In This Report
Follow us on Social Media:       

Europe In Vitro Fertilization (IVF) Market Report, published by Allied Market Research, forecasts that the European market was valued at $3,054 million in 2015 and is expected to reach $4,447 million by 2022, growing at a CAGR of 5.4% from 2016 to 2022. The fresh cycle (non-donor) segment accounted for more than three-fourths market share in 2015 and is expected to maintain its dominance during the forecast period.

Access Full Summary at: https://www.alliedmarketresearch.com/europe-IVF-services-market

The IVF market in Europe is characterized by factors such as lower fertility rates, delayed marriages, and late parenthood decisions. Subsidization of IVF treatments in Germany owing to the lowest birthrate of ~1.46 children/women is a major driving factor for the growth of this market. In addition, the National Health Plan (NHP) covers about 50% of the total treatment cost and pays for three IVF cycles, which is expected to boost the IVF market, especially in Germany. However, lack of reimbursements and high cost of the procedure limit the growth of the European IVF market.

The IVF market in Europe is anticipated to witness a continued stable growth, mainly in France, Germany, and UK. This is due to supportive regulations such as Human Fertilization and Embryo authority (HFEA) of UK, which closely regulate the functioning of IVF treatments and research in UK.

France accounted for the largest number of IVF cycles per year in 2015, whereas UK is expected to grow at the highest CAGR, in terms of volume and value. Spain is expected to be the largest contributor to overall regions revenue, growing at a CAGR of 6.1%, owing to increase in fertility tourism and high success rates for treatments provided.

Europe IVF Market Key Findings

  • Fertility clinics segment is projected to grow at the highest CAGR during the forecast period.
  • UK is expected possess the highest growth rate in the European IVF market, growing at a CAGR of 7.7%, in terms of revenue.
  • In 2015, EU5 (Germany, France, UK, Spain, and Italy) collectively accounted for approximately three-fifths share of the market volume.
  • Fresh cycle (non-donor) segment is expected be the highest revenue-generating segment, followed by thawed IVF cycle (non-donor) segment.
  • Thawed IVF cycle (non-donor) segment is projected to grow at the highest CAGR of 7.2%, in terms of volume in Denmark.

The companies profiled in this report include Thermo Fisher Scientific, Inc., DRK Kliniken Berlin, Sun Pharmaceutical Industries Ltd., Cadila Healthcare Ltd., LG Life Sciences, and EMD Serono Inc.


Need More Information

pr-det-talk Talk to David (Europe)

pr-det-talk Talk to Sona Padman (Americas)

5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States

pr-det-phone Toll Free: +1-800-792-5285

pr-det-phone UK: +44-845-528-1300

pr-det-phone Hong Kong: +852-301-84916

pr-det-phone India (Pune): +91 2066346060

pr-det-phone Fax: +1(855) 550-5975

pr-det-phone help@alliedmarketresearch.com


For Media Inquiries, Please Contact

Ram D
Communications Officer
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at


First time buyer?
Check offers and discount on this report
To get this report

Click Here

quote Europe In Vitro Fertilization (IVF) Market by Cycle Type (Fresh Cycle, Thawed IVF Cycle, and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes) - Opportunity Analysis and Industry Forecast, 2014-2022 quote

View Report

Why Allied Market Research?


Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction


On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to provide pertinent information and save time of readers


Featured Readings


Get Fresh content delivered

Get insights on topics that matter to your business. Stay updated on the area that interests you.

Get Industry Data Alerts

Buy Full Version
"Europe In Vitro Fertilization Market"
Purchase Enquiry